Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.68−0.11 (-6.15%)
Close on Nov 13, 2026Market cap $2.74MP/E –Yield –
Ernexa Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Ernexa Therapeutics's market cap was $2.26M on Nov 11, 2026, against $264.90M a year earlier. Over the last 5 years it ranged from $1.16M to $1.63T, with a median of $3.55B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.26M | -99.0% |
| 2025 | Dec 31, 2025 | $235.47M | -60.5% |
| 2024 | Dec 31, 2024 | $596.53M | -83.7% |
| 2023 | Dec 29, 2023 | $3.65B | +2.8% |
| 2022 | Dec 30, 2022 | $3.55B | -99.8% |
| 2021 | Dec 31, 2021 | $1.63T | +173.5% |
| 2020 | Dec 31, 2020 | $595.12B | +3.8% |
| 2019 | Dec 31, 2019 | $573.21B | +13.7% |
| 2018 | Dec 31, 2018 | $504.04B | +52772.1% |
| 2017 | Dec 29, 2017 | $953.31M | -99.9% |
| 2016 | Dec 30, 2016 | $1.41T | +6.3% |
| 2015 | Dec 31, 2015 | $1.33T | -63.6% |
| 2014 | Dec 31, 2014 | $3.65T | +89707.5% |
| 2013 | Dec 31, 2013 | $4.07B | +203.1% |
| 2012 | Dec 31, 2012 | $1.34B | -2.0% |
| 2011 | Dec 30, 2011 | $1.37B | – |
See a number that looks wrong?